Prosthetic Valve Endocarditis

2

Review clinical trials related to Prosthetic Valve Endocarditis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

This is a sub-study of the S. aureus Network Adaptive Platform (SNAP) trial (NCT05137119) wherein we will evaluate whether not giving rifampin in patients with probable or definite prosthetic valve endocarditis due to S. aureus is non-inferior to giving rifampin.

Participants needed: 330
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Todd C. Lee MD MPH FIDSAUpdated: Dec 10, 2025Locations: 1
Eligibility criteria

Probable or definite prosthetic valve endocarditis involving the tricuspid, pulm... [+1]

Death deemed imminent and inevitable within days or patient will be receiving pa... [+12]

Status: Recruiting

Evolution of PET Fixation With FDG at the End of Antibiotic Treatment of Infective Endocarditis on Valvular Prosthesis

In patients with prosthetic valve endocarditis (PVE) and pathological valvular FDG uptake on the initial FDG-PET and not referred to valve replacement at the acute phase, the study will assess whether FDG-PET is able to identify those at increased risk of PVE relapse.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Aug 5, 2025Locations: 1
Eligibility criteria

Patient aged 18 or over; [+4]

Patient under legal protection, guardianship or curators; [+4]